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endarterectomy with contralateral carotid occlusion
Philip P. Goodney, MD, MS,a,b Jessica B. Wallaert, MD,a Salvatore T. Scali, MD,c
David H. Stone, MD,a Virendra Patel, MD,d Palma Shaw, MD,e Brian W. Nolan, MD, MS,a,b and
Jack L. Cronenwett, MD,a,b for the Vascular Study Group of New England, Lebanon and Hanover, NH;
Gainesville, Fla; and Boston, Mass
Purpose: This study investigated the association between surgeon practice pattern in shunt placement and 30-day
stroke/death in patients undergoing carotid endarterectomy (CEA) with contralateral carotid occlusion (CCO).
Methods:Among 6379CEAs performed in the Vascular StudyGroup ofNewEngland (VSGNE) between 2002 and 2009,
we identified 353 patients who underwent CEA with CCO and compared the 30-day stroke/death rate with 5279
patients who underwent primary, isolated CEA with a patent contralateral carotid artery. Within patients with CCO, we
examined the 30-day stroke/death rate across the reason for shunt placement and two distinct surgeon practice patterns
in shunt placement: surgeons who selectively used a shunt (<95% of CEAs) or routinely used a shunt (>95% of CEAs).
We used observed/expected (O/E) ratios to provide risk-adjusted comparisons across groups.
Results: Of 353 patients with CCO, 118 (33%) underwent CEA without a shunt, 173 (49%) underwent CEA using a
shunt placed routinely, and 62 (18%) had a shunt placed for a neurologic indication. Rates of 30-day stroke/death across
categories of reason for shunt use were no shunt, 3.4%; routine shunt, 4.0%; and shunt for indication, 4.8% (P  .891).
The risk of 30-day stroke/death was higher for surgeons who selectively placed shunts (5.6%) in all their CEAs and
lower for surgeons who routinely placed shunts (1.5%, P  .05). The risk of 30-day stroke/death was >1 in patients
undergoing selective shunting (O/E ratio, 1.4; 95% confidence interval [CI], 1.1-1.7) and <1 for surgeons who
placed shunts routinely (O/E ratio, 0.4; 95% CI, 0.2-0.9). Stroke/death rates were lowest when individual
surgeons’ intraoperative decisions reflected their usual pattern of practice: 1.5% stroke/death rate when “routine”
surgeons placed a shunt, 3.4% when “selective” surgeons did not place a shunt, and 7.6% stroke/death rate for
“selective” surgeons who placed a shunt (P  .05 for trend).
Conclusions: The risk of 30-day stroke/death is higher in CEA in patients with CCO than with a patent contralateral
carotid artery. Surgeons who place shunts selectively during CEA have higher rates of stroke/death in patients with CCO.
This suggests that shunt use for CCO during CEA is associated with fewer complications, but only if the surgeon uses a
shunt as part of his or her routine practice in CEA. Surgeons should preoperatively consider their own practice pattern
in shunt use when faced with a patient who may require shunt placement. (J Vasc Surg 2012;55:61-71.)
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aSurgical decision making for patients with severe ca-
rotid atherosclerosis is complicated by the presence of a
contralateral carotid occlusion (CCO).1-4 Fewer than 10%
of carotid endarterectomies (CEAs) are performed in pa-
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doi:10.1016/j.jvs.2011.07.046ients with CCO, limiting the power of most studies to
nalyze uncommon events such as perioperative stroke
r death. Evaluation of potential methods of risk reduc-
ion during CEA with CCO is also challenging, because
f the inherent variation in patient risk factors, such as
ymptomatic or asymptomatic presentation, and surgical
echnique such as the use of eversion CEA or patch
ngioplasty.
Despite these challenges, many believe that using an
ntraoperative shunt is important for stroke reduction dur-
ng CEA in patients with CCO. Proponents argue that
hunt use ensures global perfusion, as evidenced by electro-
ncephalography (EEG) and stump pressure measure-
ent.5 Further, large clinical series have shown excellent
utcomes when shunts are placed for CEA in the setting of
CO. However, many surgeons argue that shunts are not
outinely necessary, even in patients with CCO.4,6-8 This
onclusion is justified by similarly large case series of CEAs
hat demonstrate equivalent rates of stroke with and with-
ut a shunt in CEAs in patients with and without CCO.9
ut in many of these series, CEA is performed by a high-
olume surgeon or group of surgeons who rarely place a
hunt for any reason. Whether these results can be gener-
lized to broader populations of surgeons and patients is
ncertain.
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large group of patients undergoing CEA in the setting of
CCO, we used data from the Vascular Study Group of New
England (VSGNE). We examined the outcomes of patients
undergoing CEA in the setting of CCO, with a focus on
evaluating the effect of different surgeon practice patterns
regarding shunt use within the academic and community
centers that participate in this regional registry.
METHODS
The Institutional Review Board at Dartmouth Medical
School reviewed and approved our study protocol. Within
the VSGNE, data were prospectively collected by 74 sur-
geons and associated staff in 12 hospitals (http://www.
vsgne.org). Hospital data were collected for each patient
and periodically audited against claims data to ensure entry
of all patients. Follow-up data were collected at subsequent
outpatient evaluation, with data from the visit closest to 1
year after surgery entered into the database. Further details
on this database have been published previously,10 and
others are available at http://www.vsgne.org.
Patients. Between January 1, 2003, and December
29, 2009, 5880 patients underwent 6379 primary CEAs in
New England at one of the 12 centers participating in our
registry (Fig 1). Of the 6379 CEAs, 204 patients (3.1% of
the total) did not have imaging information (duplex ultra-
sound, computed tomography [CT], or magnetic reso-
nance imaging [MRI]) available at the time of surgery and
were excluded from the analysis. Patient data were entered
into the registry preoperatively, at discharge, and at the
1-year follow-up. Mean interval of follow-up was 13.5
Fig 1. Comonths (95% confidence interval [CI], 12.6-14.5 months). dWe excluded 148 patients (2.3% of the total) who
nderwent redo CEA and 118 who had combined coro-
ary artery bypass grafting (CABG)/CEA (1.8% of the
otal). Our study cohort consisted of 353 patients with a
CO documented by preoperative imaging. Of the 5556
EAs with a patent contralateral carotid artery (performed
n 5057 patients), details on shunt placement or monitor-
ng information was unavailable in 227 patients (4%).
herefore, our comparison cohort consisted of 5279 CEAs
erformed in 4780 patients with a patent contralateral
arotid artery.
Definitions and exposure variables. The unit of anal-
sis was the operation. Patients were evaluated for pre-
xisting medical comorbidities, and these data were pro-
pectively entered into the registry by specifically trained
urgeons, nurses, or clinical data abstractors. More than 70
linical and demographic variables were collected for each
atient. Our data set was audited for completeness of
rocedural submissions using International Classification
f Diseases (9th Revision) data from each center.10,11
Themain exposure variable was the presence of a CCO,
nd the secondary exposures were the type of shunt placed
nd surgeon practice patterns in shunt placement. Demo-
raphic data and the incidence of patient-level comorbidi-
ies are outlined in Table I. CEA was categorized as con-
entional or eversion. Primary vs patch closure of the
ndarterectomy and other descriptions of the operative
echnique, such as anesthesia type, anticoagulant use, were
ecorded as well as completion study use.
Examination of the decision to place a shunt. First,
ith the patient and procedure as the unit of analysis, we
ategorized shunt use by the manner in which the shunt
as placed (Fig 1). In the VSGNE registry, shunt use
ormation.uring CEA is categorized as not used (none), placed
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Volume 55, Number 1 Goodney et al 63Table I. A, Characteristics of patients undergoing carotid endarterectomy (CEA) characteristics by presence or absence
of a contralateral carotid occlusion (CCO)
Variable
CEA performed
P
With CCO
(n  353)
Without CCO
(n  5279)
No. % No. %
Patient characteristics
Male sex 282 72.5 3210 59.3 .001
Right side 197 50.6 2585 49.0 .445
Non-white race 3 0.8 61 1.2 .319
Urgency
Elective 312 88.4 4720 89.5 .086
Urgent 41 11.6 515 9.8
Emergency (n  389) 0 0.0 41 0.8
Age, years
40 0 0.0 3 0.1 .117
40-49 15 4.3 117 2.2
50-59 54 15.3 638 12.1
60-69 103 29.2 1630 30.9
70-79 133 37.7 2024 38.3
80-89 47 13.3 830 15.7
90 1 0.3 37 0.7
Smoking (former or current) 318 90.1 4153 78.9 .001
Diabetes 104 29.5 1623 30.8 .616
Percent of patients with creatinine
1.8g m/dL
43 12.2 443 8.4 .013
Dialysis 0 0.0 38 0.7 .077
Hypertension 317 89.8 4570 86.7 .027
-blockers 297 84.6 4337 82.5 .313
Coronary disease 126 35.7 1709 32.4 .371
Prior CABG or coronary intervention 118 33.4 1662 31.5 .686
Congestive heart failure 28 8.0 385 7.3 .557
Ipsilateral degree of stenosis
50% 1 0.3 36 0.7 .321
50% 6 1.7 79 1.5
60% 12 3.4 230 4.4
70% 62 17.6 1128 21.4
80% 268 76.1 3753 71.3
Occluded 3 0.9 35 0.7
Contralateral degree of stenosis
50% 0 0.0 2983 58.5 .001
50% 0 0.0 606 11.9
60% 0 0.0 543 10.6
70% 0 0.0 601 11.8
80% 0 0.0 369 7.2
Occluded 353 100.0 0 0.0
Symptom status
Cortical symptoms (TIA or stroke) 91 25.8 1964 37.2 .003
Ocular symptoms 30 8.4 816 15.3 .001
Ipsilateral vertebrobasilar symptoms 17 4.9 130 2.5 .006
Preoperative medication regimen
No antiplatelet agent use 38 10.8 585 11.1 .020
Aspirin only 240 68.0 3851 72.9
Clopidogrel only 15 4.2 146 2.8
Aspirin, clopidogrel, or both 60 17.0 687 13.0
Statin use 274 77.8 3850 73.0 .043
Operative characteristics
General anesthesia 330 93.5 4637 87.9 .001
Shunt use (by procedure)
No shunt placed 118 33.4 2823 53.5 .001
Routine shunting 173 49.0 2209 41.9
Shunting placed for indication 62 17.6 224 4.6
Monitoring that prompted shunt
Electroencephalogram 57 192
Awake patient 3 14
Other (eg, stump pressure) 2 15
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January 201264 Goodney et albecause of routine practice (routine), or placed for a specific
indication, such as EEG changes with clamping, observed
neurologic changes in an awake patient, or low carotid
stump pressure (shunt for indication), Thus, for each CEA,
shunt use was categorized as none, routine, or for indica-
tion.
Because we sought to examine surgeon practice pat-
terns in shunt use, we then categorized each surgeon
according to his or her practice pattern in CEA by using
two mutually exclusive practice patterns: surgeons who
routinely (95% of all their CEAs) or selectively use a shunt
(95% of all their CEAs). These thresholds were estab-
lished after examination of the practice patterns in shunt
use (Fig 2) and a review of current literature.12-15 Other
thresholds were examined in sensitivity analyses of 30%,
50%, 80%, and 90% shunt use.
Outcome measures. Our main outcome measure was
30-day stroke or death after CEA. In crude analyses, we
compared unadjusted rates of 30-day stroke or death after
CEA across patients with and without CCO. Further,
within those patients who underwent CEA in the setting of
a CCO, we compared crude rates of 30-day stroke or death
across type of shunt use (none, routine, shunt for indica-
tion) as well as across surgeon practice pattern (routine or
selective).
Multivariable model to adjust for preoperative/risk
of 30-day stroke or death. After determining the crude
rates of 30-day stroke or death, we compared the crude
rates across groups with and without CCO, using
observed-to-expected (O/E) ratios. These O/E ratios
were generated by dividing the observed 30-day stroke
or death rate by the predicted 30-day stroke or death rate
for each group. These predicted risks were generated at
the patient level, based on preoperative patient charac-
teristics, using our VSGNE-specific CEA risk prediction
model. This model uses preoperative patient character-
istics (urgent need for surgery, symptom status, conges-
tive heart failure, age, and antiplatelet therapy) to predict
the risk of stroke or death 30 days after CEA.11 We
used this model because it was derived from 3000
Table I. A, Continued
Variable
With C
(n  3
No.
Shunt use by surgeon practice pattern
Selective shunter 215
Routine shunter 138
Technical aspects of CEA
Eversion endarterectomy 34
Patch angioplasty 298
Protamine 153
Completion study 130
CABG, Coronary artery bypass grafting; TIA, transient ischemic attack.CEAs in the VSGNE and has been internally and exter- sally validated. We then compared predicted and actual
ates to provide each group’s O/E ratio with surround-
ng 95% CIs. All analyses were performed using Excel
Microsoft, Redmond, Wash) and Stata software (Stata
orp, College Station, Tex).
ESULTS
Patient characteristics. Overall, patients with CCO
ere more frequently male (73%) and most commonly
ged between 70 and 79 years. Nearly all (99%) were white
Table I), and 89% were former or current smokers; 91%
ad hypertension, 30% had diabetes, and 23% had a history
f chronic obstructive pulmonary disease. By symptom
tatus, 54% were symptomatic (39% ipsilateral, 15% con-
ralateral or nonspecific) and 46% were asymptomatic. Fur-
her details about the characteristics of the cohort are
vailable in Table I.
Patients who underwent CEA for CCO differed from
he remaining CEA patients in the VSGNE registry in
everal ways. Patients with CCO were more commonly
ale (73% vs 59%), more likely to have a smoking history
90% vs 79%, P  .001), more likely to have chronic renal
nsufficiency (12% vs 8%, P .013), andmore likely to have
ypertension (91% vs 87%, P  .02). Although patients
ith CCOs tended to have more comorbidities, 39% were
ymptomatic compared with 55% of the non-CCO patients
P  .001, Table I). Lastly, patients with CCO were less
ikely to undergo surgery without a shunt (33%) compared
ith 54% of non-CCO CEAs performed without a shunt
P  .001).
Among patients with CCO, there were several differ-
nces in shunt use by patient characteristics (Table I, B).
or example, patients in whom a shunt was placed for an
ndication were more likely to be symptomatic preopera-
ively (37%) than those in whom no shunt (18%) or routine
hunting (27%) was used (P  .01). Further, patients who
nderwent urgent operations were more likely to receive a
hunt for indication (26%) vs patients undergoing elective
EA (16%; P  .018).
Rate of 30-day stroke or death. The rate of 30-day
CEA performed
P
Without CCO
(n  5279)
% No. %
60.9 3267 62.1 .809
39.1 1992 37.9
9.7 564 10.7 .427
84.4 4474 84.8 .999
43.5 2481 47.1 .461
36.8 1751 33.2 .032CO
53)troke or death was higher in patients in the setting of a CCO
p
w
o
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(4.0% vs 1.9%, P  .007, Table II). Across the 353 patients
undergoing CEA in the setting of a CCO, 14 strokes and
three deaths occurred within the first 30 days after surgery.
Table I. B, Characteristics of patients with contralateral ca
(CEA) by type of shunt (no shunt, routine shunt, or shunt
Variable
CEA with
CCO
(n  353)
No. %
Patient characteristics
Male sex 282 79.8
Right side 197 55.8
Non-white race 3 0.8
Urgency
Elective 312 88.4
Urgent 41 11.6
Emergency 0 0.0
Age, years
40 0 0.0
40-49 15 4.3
50-59 54 15.3
60-69 103 29.2
70-79 133 37.7
80-89 47 13.3
90 1 0.3
Smoking (prior or current) 318 90.1
Diabetes 104 29.5
Creatinine 1.8% 43 12.2
Dialysis 0 0.0
Hypertension 317 89.8
-blockers 297 84.6
Coronary disease 126 35.7
Prior CABG or coronary intervention 118 33.4
Congestive heart failure 28 8.0
Ipsilateral degree of stenosis
50% 1 0.3
50% 6 1.7
60% 12 3.4
70% 62 17.6
80% 268 76.1
Occluded 3 0.9
Symptom status
Cortical symptoms (TIA or stroke) 91 25.8
Ocular symptoms 30 8.4
Ipsilateral vertebrobasilar symptoms 17 4.9
Preoperative medication use
No antiplatelet agent 38 10.8
Aspirin only 240 68.0
Clopidogrel 15 4.2
Aspirin, clopidogrel, or both 60 17.0
Statin 274 77.8
Operative characteristics
General anesthesia 330 93.5
Shunt use by surgeon practice pattern
Selective shunter 215 60.9
Routine shunter 138 39.1
Technical aspects of CEA
Eversion endarterectomy 34 9.7
Patch angioplasty 298 84.4
Protamine 153 43.5
Completion study 130 36.8
CABG, Coronary artery bypass grafting; TIA, transient ischemic attack.The three deaths occurred in patients who had experienced a Wostoperative stroke. Among 5279 patients undergoing CEA
ho did not have a CCO, 100 strokes and nine deaths
ccurred, and all but three deaths were stroke-related.
Rate of 30-day stroke or death by shunt use.
occlusion (CCO) undergoing carotid endarterectomy
indication)
o shunt
 118)
Routine shunt
(n  173)
Shunt for
indication
(n  62)
P% No. % No. %
77.9 122 70.5 43 16.7 .299
47.5 110 63.5 31 50.0 .063
0.0 2 0.6 1 1.6 .391
94.9 149 86.1 51 82.3
5.1 24 13.9 11 17.7
0.0 0 0.0 0 0.0 .018
0.0 0 0.0 0 0.0
2.5 7 4.1 5 8.0
16.1 26 15.0 9 15.3
35.6 48 27.8 13 20.9
35.6 66 38.2 25 40.3
10.2 25 14.5 10 16.1
0.0 1 0.6 0 0.0 .535
91.5 152 87.9 58 93.6 .356
28.8 47 27.2 23 37.0 .333
11.0 18 10.4 12 19.4 .162
0.0 0 0.0 0 0.0 .999
91.5 153 88.4 56 90.3 .687
86.4 137 80.1 58 93.6 .034
42.4 56 32.4 20 32.3 .179
42.4 46 26.6 22 35.5 .018
4.2 16 9.3 7 11.3 .166
0.0 1 0.6 0 0.0
0.0 6 3.5 0 0.0
2.5 9 5.2 0 0.0
19.5 29 16.9 10 16.1
78.0 124 72.1 52 83.9
0.0 3 1.7 0 0.0 .106
17.8 47 27.2 23 37.1 .016
5.0 19 10.9 5 8.0 .394
2.5 11 6.4 3 4.8 .594
11.0 20 11.5 5 8.0
76.3 106 61.3 44 71.0 .997
2.5 8 4.6 4 6.5 .673
9.3 42 24.3 7 11.3 .083
82.2 134 77.9 43 69.4 .143
85.6 170 98.3 59 96.2 .001
98.3 37 21.4 62 100.0 .001
0.8 136 78.6 0 0.0
20.5 2 1.2 8 12.9 .001
71.2 165 95.4 49 79.0 .001
24.6 106 61.3 18 29.5 .001
34.8 69 39.9 20 32.3 .479rotid
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categories of shunt use: no shunt, 3.4%; routine shunt,
4.1%; shunt for indication, 4.8% (P  .8, Table II).
Patient characteristics between the three categories of
0
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75
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Fig 2. Surgeon practice patterns in sh
Table II. A, Rate of 30-day stroke or death after carotid e
(CCO) status
Variable
CEA with CCO
(n  353)
No. %
30-day stroke 14 3.9
30-day death 3 0.7
30-day stroke or death 14 3.9
aP value from Fisher exact test.
Table II. B, Rate of 30-day stroke or death after carotid e
(CCO) status and surgeon practice pattern for shunt placem
Variable
CEA with CCO (n  353)
No shunt
No. (%)
Routine
shunt
No. (%)
Placed fo
indicatio
No. (%)
30-day stroke 4/118 (3.3) 7/173 (4.0) 3/62 (4.8
30-day death 1/118 (0.1) 1/173 (0.1) 1/62 (0.1
30-day stroke/death 4/118 (3.4) 7/173 (4.0) 3/62 (4.8
bP value from Fisher exact test.shunt use did not vary significantly, and therefore, the oredicted 30-day stroke or death rate risk across the
hree groups was not different: no shunt, 3.4%; routine
hunt, 4.0%; and shunt for indication, 4.3% (P  .891).
he O/E ratios (95% CIs) were similar across categories
7 39 41 43 45 47 49 51 53 55 57 59 61 63 65 67 69 71 73
Roune Surgeon Pracce Paern:
Surgeon Uses Shunt in >95% of CEAs
(28 Surgeons, 38% of all CEAs)
on ID
se in carotid endarterectomy (CEA).
terectomy (CEA) by contralateral carotid occlusion
CEA without CCO
(n  5279)
PaNo. %
100 1.78 .002
9 0.1 .471
102 1.93 .007
terectomy (CEA) by contralateral carotid occlusion
CEA without CCO (n  5279)
Pb
No shunt
No. (%)
Routine shunt
No. (%)
Placed for
indication
No. (%) Pb
.883 46/2824 (1.6) 41/2210 (1.8) 9/245 (3.7) .016
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Volume 55, Number 1 Goodney et al 67(0.4-2.4); and shunt for indication, 1.1 (0.3-3.0). These
results showed that when we adjusted for patient char-
acteristics, there were no significant differences in rates
of 30-day stroke or death across categories of shunt
use.
For comparison, rates of 30-day stroke or death across
categories of shunt in patients without CCO are reported in
Table II. The risk of 30-day stroke or death was signifi-
cantly higher in patients in whom a shunt is placed for an
indication (4.1%) compared with routinely placed shunts
(1.9%) or patients in whom shunts were not placed (1.7%;
P  .03).
Rate of 30-day stroke or death by surgeon practice
pattern in shunt use. As shown in Fig 2, 46 of the 74
surgeons in our data set placed shunts selectively. Selective
surgeons performed 62% of all CEAs in our data set,
including 215 of the 353 (61%) CEAs with CCOs in our
study. Of the 46 selective surgeons, 40 (87%) used a shunt
in 30% of their CEAs. Conversely, 28 surgeons routinely
shunted, and these surgeons performed 38% of all CEAs in
our data, including 137 of the 353 (39%) CEAs with CCO
in our study.
Surgeons who routinely used shunts in all their CEAs
had a 30-day stroke or death rate of 1.5% in patients with
CCOs, which was significantly lower than the rate of
5.6% in surgeons who used shunts selectively (P  .05;
Table III). This difference was unlikely to be secondary
to differences in patient characteristics between the two
cohorts, because predicted risks according to patient
characteristics were similar between these groups (3.9%
vs 3.9%, P  .961), and patient characteristics associated
with stroke or death were also similar in both groups
(Table IV). The O/E ratio was 1 in patients undergo-
ing selective shunting (1.4; 95% CI, 1.1-1.7), indicating
higher than expected stroke risk. However, the O/E
ratio was 1 for surgeons who placed shunts routinely
(0.4; 95% CI, 0.2-0.9), indicating lower than expected
risk of stroke or death according to preoperative patient
characteristics.
Finally, we examined the rate of 30-day stroke or
death by shunt use and surgeon practice pattern (Fig 3).
Surgeons classified as “routine” shunters had the lowest
overall rate of 30-day stroke or death when they placed a
shunt (1.5%, Fig 3). Surgeons classified as “selective”
Table III. Rate of 30-day stroke or death in patients unde
pattern (surgeon shunts routinely, surgeon shunts selective
Variable
CEA with CCO (n  353)
Shunts routinely
No. (%)
Shunts selectivel
No. (%)
30-day stroke 2/138 12/215
30-day death 1/138 2/215
30-day stroke/death 2/138 (1.5%) 12/215 (5.6%
aP value from Fisher’s exact test.shunters had a rate of 30-day stroke or death of 3.4% ohen they chose not to place a shunt in patients with
CO. The rate of 30-day stroke or death was highest
7.6%) for selective surgeons who chose to place a shunt
uring a CEA with CCO. As with our previous results,
hese differences are not likely to be due to differences in
atient characteristics, because predicted risks of 30-day
troke or death did not vary significantly across groups
4.0%, 3.4%, 4.3%, respectively, Fig 3). When we calcu-
ated O/E ratios, we found that “routine” surgeons who
hunted routinely performed slightly better than ex-
ected (0.4; 95% CI, 0.2-0.8), “selective” surgeons who
id not shunt performed as expected (0.9; 95% CI,
.7-1.2), and “selective” surgeons who placed a shunt
erformed slightly worse than expected (1.7; 95% CI,
.2-2.1; P  .05 for trend across O/E ratios).
Finally, we performed a sensitivity analysis around our
efinition of “selective” shunt placement (95% of all CEAs)
o examine if our findings were due to adverse events
ccurring in selective surgeons who placed a shunt fre-
uently, such as in 30%, 50% or 90% of their CEAs. As
hown in the Appendix (online only), our results did not
hange if we eliminated from the analysis any CEA in the
etting of a CCO, wherein a “selective” surgeon placed a
hunt in more than 30%, 50%, or 90% of non-CCO cases.
his finding reflects the fact that the operations in most
atients who underwent surgery in the setting of a CCO
ere performed by surgeons who clustered at the lower
30%) and higher (95%) ends of practice patterns. Only
1 CEAs with CCO (3% of the total) were performed by
urgeons who shunted between 30% and 95% of their cases,
nd none of these patients experienced postoperative stroke
ng carotid endarterectomy (CEA) by surgeon practice
nd contralateral carotid occlusion (CCO) status
CEA without CCO (n  5279)
Pa
Shunts routinely
No. (%)
Shunts selectively
No. (%) Pa
.027 35/1992 64/3287 .471
.443 2/1992 4/3287 .636
.054 36/1992 (1.81%) 66/3287 (2.02%) .587
able IV. Factors associated with 30-day stroke or
eath, by surgeon practice pattern
ariable
Shunts
selectively (%)
Shunts
routinely (%) P
ge 80 years 14.9 11.7 .494
spirin or clopidogrel use 87.0 91.0 .182
ongestive heart failure 7.5 8.8 .665
rgent procedure 10.2 13.9 .3
ortical ipsilateral symptoms 7.4 5.1 .688rgoi
ly) a
y
)r death.
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Within our series of 353 primary CEAs performed in
patients with CCO, the risk of 30-day stroke or death was
higher in patients with CCO than in patients without CCO.
Further, our data indicate that surgeons who placed shunts
routinely had low rates of 30-day stroke or death when they
placed a shunt, and surgeons who did not routinely use a
shunt and performed CEA in the setting of CCO without a
shunt also had low rates of 30-day stroke or death, but only
when they did not place a shunt. The highest risk-adjusted
chance of stroke or death occurred when surgeons who did
not typically use a shunt placed a shunt during CEA in the
setting of a CCO. Therefore, surgeons should consider their
own practice pattern in shunt use preoperatively when faced
with a patient who may require shunt placement.
Themarginal risk imparted inCEAwhen the contralateral
carotid artery is occluded has long been a topic of debate
among vascular surgeons. Secondary data analyses from the
North American Symptomatic Carotid Endarterectomy Trial
(NASCET)16,17 and the Asymptomatic Carotid Atheroscle-
rosis Study (ACAS)18 demonstrated increased rates of stroke
or death among patients with CCO undergoing CEA. How-
ever in 2007, Dalainas et al19 studied 2959 CEAs, 373 of
which were performed in patients with CCO, and found no
significant difference in perioperative stroke or death between
patients with and without CCO. A similar-sized study per-
formed by Rockman et al14,15 also found similar rates of
perioperative stroke or death between patients with and with-
out CCO. Most studies have found little difference in out-
comes after CEA among patients with CCO (Table V, A).
The role of shunt placement during CEA is also widely
Fig 3. Predicted and observed 30-day stroke and death
type and surgeon practice pattern.debated. Several prior series and a recently updated meta- pnalysis of randomized trials found no significant difference
n outcomes after CEA among surgeons who routinely
hunt and those who selectively shunt.34 In the subset of
EAs with CCO, multiple observational studies have also
ound no impact of shunting on stroke or death after CEA
ith CCO (Table V, A-C).
Our results demonstrate an increased risk of stroke or
eath for CEA performed in the presence of CCO and that
urgeons who shunt infrequently incur an increased risk of
troke when shunting is performed. Debate regarding the
nfluence of these two covariates (CCO status and shunt use)
n the stroke and death risk will undoubtedly continue. Our
tudy adds to the current debate in two ways:
First, our study represents a large number of patients
ndergoing CEA with CCO in a real-world setting of
ixed academic and community practice.
Second, our study indicates that surgeons who rou-
inely place shunts during all their CEAs have better results
han surgeons who place shunts selectively in the setting of
CCO, a novel observation in carotid surgery.
We believe a relationship may exist between the routine
erformance of a technically demanding process of care in
urgery and better outcomes. Relationships such as these have
ultiple precedents in surgery. For example, the use of left
nterior mammary artery grafts during coronary artery bypass
rafting and routine cholangiography during laparoscopic
holecystectomy35,36 are both commonly referenced exam-
les of the association between routine performance of com-
lex processes of carewith better surgical outcomes. Although
ndirect, our data suggest that the surgeons who perform
hunt placement routinely are those who are most likely to
patients with a contralateral carotid occlusion by shuntrate inerform it safely.Conversely, if anunplanned shunt is required
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shunt user had a substantially higher stroke/death rate.
Do our results suggest that shunt placement should be
always be performed in CEA in the setting of CCO? We
believe the answer is no. Rather, we believe our data suggest
that the safest operation a surgeon canprovide in the setting of
a CCO is the operation that the surgeon would perform
without the CCO being present. In other words, surgeons
who shunt routinely fared best when they routinely placed
shunts, and selective surgeons, on average, obtained the best
results when they performed CEA in the way they most
commonly performed the operation—without a shunt. We
believe that surgeons can use our study to inform their preop-
erative decision making when faced with a patient likely to
need a shunt, such as a patient with a CCO and an incomplete
circle of Willis. In this setting, selective surgeons may choose
to use strategies to limit the need for shunting, such as
permissive hypertension, or refer the patient to a colleague
who places shunts commonly. However, our study is small
and will need to be replicated in larger settings before these
conclusions are made.
Our study has limitations. Many will argue that our
study, which is observational in nature, cannot fully ac-
count for patient differences or intraoperative events that
led surgeons who do not usually shunt to place a shunt
during a high-risk CEA. And although our observational
data set does not obviate bias or confounding as a random-
ized trial might, our validated multivariable risk model fails
to demonstrate any significant differences in patient char-
Table V. A, Outcomes between carotid endarterectomy (
occlusion (CCO), in the presence or absence of a shunt
Author (year)
CCO
cases
CCO cases
using shunt
Stroke/death
rate in CCO
Shunt
No
Shu
No. % (No.) % (No.) % (N
Locatic,20 (2000) 198 83.3 (165) 4.2 (7) 3.0 (
Ballottad,13 (2002) 68 52.9 (36) 0 6.3 (
Schneiderd,21 (2002) 57 55 (31) 0 0
Cinar9 (2004) 55 10.9 (6) 50 (3) 0
Ballotta22 (2004) 135 54 (73) 0 4.8 (
Fitzpatrick23 (2005) 16 68.8 (11) 9.1 (1) 0
Ballottae,13 (2002) 68 52.9 (36) 1.4 (1)f
Schneidere,21 (2002) 57 55 (31) 1.8 (1)f
Pulli24 (2002) 82 25.6 (21) 2.4f
Rockmand,14,15 (2002, 2004) 338 66.2 (224) 3.0f
Rockmane,14,15 (2002, 2004) 338 66.2 (224) 0.6 (2)f
Domenig25 (2003) 112 82.1 (92) 3.6 (4)f
Bellosta26 (2006) 36 100 8.3 (3)f
Dalainas19 (2007) 373 28.7 (107) 4.0 (15)f
aDoesn’t report. Stroke/death rate by shunt use or shunt use was 0% or 10
bData extracted/combined from original article and assessed by this author
cRates reported include transient ischemic attack.
dComplication rates reflect perioperative stroke only (mortality excluded).
eComplication rates reflect perioperative mortality only (stroke excluded).
fStudies did not provide data about shunt use.acteristics that may explain our findings. tSecond, our designation of surgeon practice pattern was
stablished using data from the surgeon’s practice pattern not
n the setting of a CCO, and most surgeons designated as
selective” shunters were indeed selective (ie, shunted infre-
uently) in the use of this process of care. Many believe that
he use of a shunt in 90% of cases more closely represents
routine” use. However, our sensitivity analyses of the effect
f different cut points, such as 30%, 50%, 80%, and90%, found
ittle difference in the direction or magnitude of effect of our
ndings.
Third, the use of neuromonitoring differs across sur-
eons: some use EEG, others awake CEA, and still others
se stump pressure as an indicator to place a “shunt for
ndication.” We found no systematic evidence that these
hoices varied dramatically by surgeon practice pattern, but
he nonrandomized nature of this covariate could poten-
ially introduce bias.
Fourth, given the nonrandomized nature of our data
et, we are unable to infer what might have occurred if a
elective surgeon had chosen not to place a shunt during
ne of the cases in which he or she shunted for an indica-
ion.
Finally, beyond the debates surrounding the technical
oints of carotid surgery, all interested parties (surgeons,
ayers, and patients) agree that procedure-specific quality
easures are needed to most effectively measure and im-
rove performance.37 At the outset of this project, we
ypothesized that shunt use would be associated with
etter outcomes for CEA in the setting of CCO. It seemed
) patients with and without contralateral carotid
omparison
of 30-day
roke/death
Non-
CCO
cases
Non-CCO
cases
using shunt
Stroke/death
rate in non-CCO
Comparison
of 30-day
stroke/death
hunt vs no
shunt
Shunt
No
shunt b/w CCO
and non-
CCOa(%) % (No.) % (No.) % (No.)
NS 1068 8.9 (96) 2.3 (25) NS
NS 268 4.8 (13) 23.1 (3) 0 NSb
NS 507 13 (66) 7.6 (5) 0 NSb
.001 374 9.1 (34) 8.8 (3) 0.9 (3) NSb
NS 38 15.7 (6) 0f NS
NS 154 46.7 (72) 2.6 (4)f NS
268 4.8 (13) 0.7 (2)f NSb
507 13 (66) 0.2 (1)f NSb
1242 6.9 (86) 1.4f NS
2082 27.3 (568) 2.1f NS
2082 27.3 (568) 0.1 (2)f NSb
1752 76.9 (1348) 1.9 (33)f NS
706 100 0.42 (3)f .001a
2959 7.1 (210) 3.6 (107)f NS
2 with Fisher’s exact test.CEA
C
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specific quality indicator in vascular surgery. However, as
outlined above, our registry data refuted this hypothesis,
leading us to conclude that shunt use is not a useful quality
measure because surgeons can achieve excellent outcomes
with or without using a shunt. This process illustrates the
need for vascular surgeons to become active participants in
developing and vetting quality measures, a process that will
often require detailed clinical data from representative,
real-world practice.
CONCLUSIONS
Within our multicenter registry, the risk of 30-day stroke
was significantly higher in patients with CCO. Further, al-
though shunt use itself was not directly associated with lower
rates of 30-day stroke/death, surgeons who use a shunt infre-
quently during any CEA have higher rates of stroke/death
when treating patients with a CCO with a shunt. Our results
suggest that shunt use in CEA with CCO is associated with a
lower rate stroke/death, but only if the surgeonuses a shunt as
part of his or her routine practice.
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